With an initial investment of over 17 million euros for the development of 5,600 square meters of new laboratories dedicated to pharmaceutical technology and analytical chemistry, Alfasigma confirms its commitment to Research and Development. L’inauguration of ‘Labio 4.0 Marino Golinelli’, this morning in the Pomezia pharmaceutical group plant, is part of a broader corporate strategy of progressive investment in R&D, which allows Alfasigma, one of the top five pharmaceutical companies with Italian capital, to stand out both nationally and internationally for innovation and technological development.
Read Also
- Ghost of Tsushima and its payment improvement on PS5 does not convince readers: 94% reject it Jul 9, 2021
- Two women overwhelmed and killed in a field. The cousin: “They were with two friends, where did they go?” Jul 5, 2021
- University of Guanajuato starts back to classes in a hybrid way Aug 9, 2021
- Canary Island Consequences | Costa Tropical Gazette News Sep 20, 2021
- Al Bano Carrisi irrepressible with Orietta Berti. Pinched in the car like that Jul 30, 2021
- Switzerland: A father abducts his two children, an appeal for witnesses launched Nov 22, 2022
- The Federation sees LaLiga’s agreement with CVC as “illegal” Aug 11, 2021